4beta-Hydroxywithanolide E has been researched along with withaferin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brooks, AD; Gunatilaka, AA; Henrich, CJ; Sayers, TJ; Tewary, P; Wijeratne, EM; Xu, YM | 1 |
1 other study(ies) available for 4beta-Hydroxywithanolide E and withaferin a
Article | Year |
---|---|
17β-Hydroxywithanolides as Sensitizers of Renal Carcinoma Cells to Tumor Necrosis Factor-α Related Apoptosis Inducing Ligand (TRAIL) Mediated Apoptosis: Structure-Activity Relationships.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Ergosterol; Humans; Kidney; Kidney Neoplasms; Structure-Activity Relationship; TNF-Related Apoptosis-Inducing Ligand; Withania; Withanolides | 2017 |